|
|
 |
Your Online Resource for Diabetes Treatment
Home > Literature
Alerts > Archived
by Topic > Other
Other | 
|
| |
Aspirin use and risk of type 2 diabetes in apparently healthy men
Hayashino Y, Hennekens CH, Kurth T Am J Med. 2009;122(4):374-379 |
| |
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial
Ogawa H, Nakayama M, Morimoto T, Uemura S, et al, for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators JAMA. 2008;300(18):2134-2141 |
| |
An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients
Koro CE, Fu Q, Stender M Pharmacoepidemiol Drug Saf. 2008;17(10):989-986 |
| |
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Gaede P, Lund-Andersen H, Parving HH, Pedersen O ACC Abstracts of the 48th Scientific Session. 358(6):580-91 |
| |
Effects of torcetrapib in patients at high risk for coronary events
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators N Engl J Med. 357(21):2109-22 |
| |
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial
Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A. ACC Abstracts of the 48th Scientific Session. 335(7611):132 |
| |
Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes.
Grover-Páez F, Villegas Rivera G, Guillén Ortíz R ACC Abstracts of the 48th Scientific Session. 78(1):136-40 |
| |
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension
Park H, Hasegawa G, Obayashi H, et al Clin Chimica Acta.. 2006;374:129-134 |
| |
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome
Bakris G, Molitch M, Hewkin A, et al, for the STAR Investigators Diabetes Care. 2006;29:2592-2597 |
| |
Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
Bowden DW, Lohman K, Hsu FC, et al Diabet Med. 2006;23:763-767 |
|